title: Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers.
abstract: MPO participates in the metabolic activation of tobacco carcinogens such as PAHs. A frequent MPO -463 G-->A polymorphism in the promoter region reduces MPO transcription and has been correlated with >4-fold lower benzo[a]pyrene-DNA adduct levels in the skin of coal tar-treated patients. Four of 7 case-control studies found significantly reduced lung cancer risk associated with the A allele. Due to their different etiologies, we examined whether the MPO genotype affects histologic lung cancer types differentially. A case-control study was conducted in 625 ever-smoking lung cancer patients, including 228 adenocarcinomas, 224 SCCs, 135 SCLCs and 340 ever-smoking hospital controls. MPO genotyping was performed by capillary PCR followed by fluorescence-based melting curve analysis. Combining the MPO -463 (G/A+A/A) genotypes, a protective effect approaching significance (OR = 0.75, 95% CI 0.55-1.01) was observed when comparing all lung cancer cases to controls. Among histologic types of lung cancer, a weak protective effect was found for both adenocarcinoma (OR = 0.81, CI 0.55-1.19) and SCC (OR = 0.82, CI 0.56-1.21); a stronger and significant effect was found for SCLC (OR = 0.58, CI 0.36-0.95; p = 0.029). Our results also suggest that the MPO genotype varies among inflammatory nonmalignant lung diseases. In conclusion, our results emphasize the need for a separate analysis of lung cancer histologic types and an adjustment for inflammatory nonmalignant lung diseases in future MPO-related studies. We confirm that the MPO -463 A variant affords a protective effect against lung cancer risk in smokers, which was strongest for SCLC patients.
authors.affiliation: Division of Toxicology and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany. h.dally@dkfz.de
authors.forename: Heike
authors.initials: H
authors.lastname: Dally
authors.forename: Kai
authors.initials: K
authors.lastname: Gassner
authors.forename: Birgit
authors.initials: B
authors.lastname: Jäger
authors.forename: Peter
authors.initials: P
authors.lastname: Schmezer
authors.forename: Bertold
authors.initials: B
authors.lastname: Spiegelhalder
authors.forename: Lutz
authors.initials: L
authors.lastname: Edler
authors.forename: Peter
authors.initials: P
authors.lastname: Drings
authors.forename: Hendrik
authors.initials: H
authors.lastname: Dienemann
authors.forename: Volker
authors.initials: V
authors.lastname: Schulz
authors.forename: Klaus
authors.initials: K
authors.lastname: Kayser
authors.forename: Helmut
authors.initials: H
authors.lastname: Bartsch
authors.forename: Angela
authors.initials: A
authors.lastname: Risch
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics; D000328:Adult; D000483:Alleles; D018288:Carcinoma, Small Cell / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D018307:Neoplasms, Squamous Cell / Q000235:genetics; D009195:Peroxidase / Q000235:genetics*; D012306:Risk; D012907:Smoking
chemical_list: D009195:Peroxidase